Gamble Jones Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $15.5M | Sell |
96,205
-145
| -0.2% | -$22.2K | 1.17% | 19 |
|
|
2022
Q3 | $12.9M | Sell |
96,350
-3,344
| -3% | -$480K | 1.05% | 21 |
|
|
2022
Q2 | $15.3M | Sell |
99,694
-7,387
| -7% | -$1.13M | 1.13% | 18 |
|
|
2022
Q1 | $17.4M | Sell |
107,081
-1,824
| -2% | -$265K | 1.08% | 21 |
|
|
2021
Q4 | $14.7M | Sell |
108,905
-690
| -0.6% | -$81.5K | 0.87% | 24 |
|
|
2021
Q3 | $11.8M | Sell |
109,595
-6,352
| -5% | -$726K | 0.77% | 30 |
|
|
2021
Q2 | $13.1M | Sell |
115,947
-2,399
| -2% | -$270K | 0.85% | 27 |
|
|
2021
Q1 | $12.8M | Sell |
118,346
-1,887
| -2% | -$202K | 0.86% | 25 |
|
|
2020
Q4 | $12.9M | Sell |
120,233
-8,912
| -7% | -$856K | 0.88% | 26 |
|
|
2020
Q3 | $11.3M | Buy |
129,145
+217
| +0.2% | +$20.4K | 0.82% | 29 |
|
|
2020
Q2 | $12.7M | Sell |
128,928
-1,143
| -0.9% | -$101K | 1.01% | 25 |
|
|
2020
Q1 | $9.91M | Sell |
130,071
-2,909
| -2% | -$248K | 0.91% | 27 |
|
|
2019
Q4 | $11.8M | Buy |
132,980
+3,058
| +2% | +$254K | 0.92% | 30 |
|
|
2019
Q3 | $9.84M | Sell |
129,922
-8,987
| -6% | -$616K | 0.81% | 32 |
|
|
2019
Q2 | $10.1M | Sell |
138,909
-7,223
| -5% | -$568K | 0.86% | 30 |
|
|
2019
Q1 | $11.8M | Sell |
146,132
-2,086
| -1% | -$171K | 1.04% | 24 |
|
|
2018
Q4 | $13.7M | Sell |
148,218
-6,356
| -4% | -$559K | 1.37% | 13 |
|
|
2018
Q3 | $14.6M | Sell |
154,574
-4,908
| -3% | -$465K | 1.35% | 14 |
|
|
2018
Q2 | $14.8M | Sell |
159,482
-2,892
| -2% | -$282K | 1.48% | 13 |
|
|
2018
Q1 | $15.4M | Sell |
162,374
-4,302
| -3% | -$473K | 1.53% | 11 |
|
|
2017
Q4 | $16.1M | Sell |
166,676
-32,788
| -16% | -$3.09M | 1.53% | 9 |
|
|
2017
Q3 | $17.7M | Sell |
199,464
-8,043
| -4% | -$612K | 1.81% | 9 |
|
|
2017
Q2 | $15M | Sell |
207,507
-310
| -0.1% | -$20.8K | 1.58% | 10 |
|
|
2017
Q1 | $13.5M | Sell |
207,817
-15,772
| -7% | -$992K | 1.43% | 10 |
|
|
2016
Q4 | $14M | Sell |
223,589
-2,694
| -1% | -$164K | 1.55% | 9 |
|
|
2016
Q3 | $14.3M | Sell |
226,283
-8,939
| -4% | -$579K | 1.55% | 10 |
|
|
2016
Q2 | $14.6M | Sell |
235,222
-57,233
| -20% | -$3.49M | 1.59% | 9 |
|
|
2016
Q1 | $16.7M | Sell |
292,455
-1,205
| -0.4% | -$67.2K | 1.86% | 9 |
|
|
2015
Q4 | $17.4M | Sell |
293,660
-2,322
| -0.8% | -$134K | 1.92% | 9 |
|
|
2015
Q3 | $16.1M | Buy |
295,982
+5,113
| +2% | +$333K | 1.85% | 10 |
|
|
2015
Q2 | $19.5M | Buy |
290,869
+1,287
| +0.4% | +$84K | 2.03% | 7 |
|
|
2015
Q1 | $17M | Buy |
289,582
+2,295
| +0.8% | +$139K | 1.76% | 9 |
|
|
2014
Q4 | $18.8M | Sell |
287,287
-3,893
| -1% | -$245K | 1.94% | 6 |
|
|
2014
Q3 | $16.8M | Sell |
291,180
-571
| -0.2% | -$31.7K | 1.86% | 8 |
|
|
2014
Q2 | $16.5M | Sell |
291,751
-12,203
| -4% | -$640K | 1.84% | 7 |
|
|
2014
Q1 | $15.6M | Sell |
303,954
-3,318
| -1% | -$168K | 1.82% | 7 |
|
|
2013
Q4 | $16.2M | Sell |
307,272
-4,687
| -2% | -$230K | 1.91% | 7 |
|
|
2013
Q3 | $14M | Sell |
311,959
-945
| -0.3% | -$41.9K | 1.79% | 8 |
|
|
2013
Q2 | $12.9M | Buy |
+312,904
| New | +$13.7M | 1.71% | 9 |
|
Other funds holding ABBV
AWA
Gamble Jones Investment Counsel's ABBV Position: Q4 2022 in Review
Gamble Jones Investment Counsel reduced its AbbVie (ABBV) stake by 0.15% in Q4 2022, selling an estimated $22.2K and leaving 96,205 shares worth $15.5M. The position accounts for 1.17% of the portfolio, ranked #19.
Gamble Jones Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 39 quarters since. The position peaked at $19.5M in Q2 2015. 3,168 funds tracked by Wall St. Rank hold ABBV as of Q4 2022.
- Gamble Jones Investment Counsel held 96,205 shares of AbbVie worth $15.5M as of Q4 2022.
- Gamble Jones Investment Counsel sold 145 AbbVie shares in Q4 2022, an estimated $22.2K.
- AbbVie made up 1.17% of Gamble Jones Investment Counsel's portfolio in Q4 2022, its #19 holding.
- Gamble Jones Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 39 quarters since.
- Gamble Jones Investment Counsel's AbbVie position peaked at $19.5M in Q2 2015.
- 3,168 funds tracked by Wall St. Rank held AbbVie as of Q4 2022.
Based on Gamble Jones Investment Counsel's 13F filing for Q4 2022, filed 8 Feb 2023.